Millipore Sigma Vibrant Logo

OP13L Anti-N-Myc Mouse mAb (NCM II 100)

Anti-N-Myc Mouse mAb (NCM II 100): Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
OP13L
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Tabla espec. clave

      Species ReactivityHostAntibody Type
      H, MMMonoclonal Antibody
      Description
      Overview

      This product has been discontinued.



      Recognizes N-myc as well as its cleavage products in IMR5 cells. Myc is a labile protein. Fresh lysates in the presence of protease inhibitor cocktails are recommended.

      Catalogue NumberOP13L
      Brand Family Calbiochem®
      References
      ReferencesBrondyk, W.H. 1991. Oncogene 6, 1269.
      Ikegaki, N., et al. 1988. Adv. Neuroblastoma Research. 2, 133.
      LeGouy, E., et al. 1987. In Nuclear Oncogenes, Cold Spring Harbor Laboratory, 144.
      Cole, M.D., 1986. Annu. Rev. Gen. 20, 361.
      Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929.
      Slamon, D.J., et al. 1986. Science 232, 768.
      Seeger, R.C., et al. 1985. New Engl. J. Med. 313, 1111.
      Brodeur, G.M., et al. 1984. Science 224, 1121.
      Michitsch, R.W., et al. 1984. Mol. Cell. Biol. 11, 2370.
      Kohl, N.E., et al. 1983. Cell 35, 603.
      Schwab, M., et al. 1983. Nature 305, 245.
      Product Information
      FormLyophilized
      FormulationLyophilized from a volatile buffer, 100 µg BSA.
      Positive controlIMR5 cells
      PreservativeNone
      Quality LevelMQ100
      Applications
      Application ReferencesOriginal Clone, Immunofluorescence Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929. Immunoblotting Brondyk, W.H. 1991. Oncogene 6, 1269. Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929. Immunoprecipitation Brondyk, W.H. 1991. Oncogene 6, 1269.
      Key Applications Frozen Sections
      Immunoblotting (Western Blotting)
      Immunofluorescence
      Immunoprecipitation
      Application NotesFrozen Sections (1-5 µg/ml)
      Immunoblotting (1-5 µg/ml, see application references)
      Immunofluorescence (1-5 µg/ml, see application references)
      Immunoprecipitation (1-2 µg/sample, see application references)
      Application CommentsIt is important to compensate for the short half life of this protein when preparing tissue sections or extracts. We recommended that all preparations be kept cold and that a cocktail of protease inhibitors be used. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenrecombinant, human, N-Myc fusion protein, expressed in E. coli
      ImmunogenHuman
      CloneNCM II 100
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      • Mouse
      Antibody TypeMonoclonal Antibody
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsReconstitute the lyophilized antibody with 1 ml sterile PBS. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide. Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      OP13L 0

      Documentation

      Anti-N-Myc Mouse mAb (NCM II 100) Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Anti-N-Myc Mouse mAb (NCM II 100) Certificados de análisis

      CargoNúmero de lote
      OP13L

      Referencias bibliográficas

      Visión general referencias
      Brondyk, W.H. 1991. Oncogene 6, 1269.
      Ikegaki, N., et al. 1988. Adv. Neuroblastoma Research. 2, 133.
      LeGouy, E., et al. 1987. In Nuclear Oncogenes, Cold Spring Harbor Laboratory, 144.
      Cole, M.D., 1986. Annu. Rev. Gen. 20, 361.
      Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929.
      Slamon, D.J., et al. 1986. Science 232, 768.
      Seeger, R.C., et al. 1985. New Engl. J. Med. 313, 1111.
      Brodeur, G.M., et al. 1984. Science 224, 1121.
      Michitsch, R.W., et al. 1984. Mol. Cell. Biol. 11, 2370.
      Kohl, N.E., et al. 1983. Cell 35, 603.
      Schwab, M., et al. 1983. Nature 305, 245.

      Citas

      Título
    • Hongjuan Cui, Tai Li and Han-Fei Ding. (2005) Linking of n-myc to death receptor machinery in neuroblastoma cells. Journal of Biological Chemistry 280, 9474-9481.
      		•
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-October-2007 RFH
      ApplicationFrozen Sections (1-5 µg/ml)
      Immunoblotting (1-5 µg/ml, see application references)
      Immunofluorescence (1-5 µg/ml, see application references)
      Immunoprecipitation (1-2 µg/sample, see application references)
      DescriptionPurified mouse monoclonal antibody derived by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with SP2/0 mouse myeloma cells (see application references). Recognizes N-myc as well as its cleavage products.
      BackgroundThe v-myc oncogene, initially identified in the MC29 avian retrovirus, causes myelocytomas, carcinomas, sarcomas and lymphomas, and belongs to a family of oncogenes conserved throughout evolution. In humans the family consists of five genes: c-myc, N-myc, R-myc, L-myc and B-myc. Amplification of the N-myc gene has been found in human neuroblastomas and cell lines. The extent of N-myc amplification correlates well with the stage of neuroblastoma disease. Immunological studies have shown that the human N-myc gene gives rise to at least two nuclear phosphoproteins of ~64 kDa and ~67 kDa that exhibit relatively short (30 min) half lives in vivo and exhibit DNA binding properties in vitro.
      HostMouse
      Immunogen speciesHuman
      Immunogenrecombinant, human, N-Myc fusion protein, expressed in E. coli
      CloneNCM II 100
      IsotypeIgG₁
      Specieshuman, mouse
      Positive controlIMR5 cells
      FormLyophilized
      FormulationLyophilized from a volatile buffer, 100 µg BSA.
      PreservativeNone
      CommentsIt is important to compensate for the short half life of this protein when preparing tissue sections or extracts. We recommended that all preparations be kept cold and that a cocktail of protease inhibitors be used. Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsReconstitute the lyophilized antibody with 1 ml sterile PBS. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide. Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      ReferencesBrondyk, W.H. 1991. Oncogene 6, 1269.
      Ikegaki, N., et al. 1988. Adv. Neuroblastoma Research. 2, 133.
      LeGouy, E., et al. 1987. In Nuclear Oncogenes, Cold Spring Harbor Laboratory, 144.
      Cole, M.D., 1986. Annu. Rev. Gen. 20, 361.
      Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929.
      Slamon, D.J., et al. 1986. Science 232, 768.
      Seeger, R.C., et al. 1985. New Engl. J. Med. 313, 1111.
      Brodeur, G.M., et al. 1984. Science 224, 1121.
      Michitsch, R.W., et al. 1984. Mol. Cell. Biol. 11, 2370.
      Kohl, N.E., et al. 1983. Cell 35, 603.
      Schwab, M., et al. 1983. Nature 305, 245.
      Citation
    • Hongjuan Cui, Tai Li and Han-Fei Ding. (2005) Linking of n-myc to death receptor machinery in neuroblastoma cells. Journal of Biological Chemistry 280, 9474-9481.
      		•
      Application referencesOriginal Clone, Immunofluorescence Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929. Immunoblotting Brondyk, W.H. 1991. Oncogene 6, 1269. Ikegaki, N., et al. 1986. Proc. Natl. Acad. Sci. USA 83, 5929. Immunoprecipitation Brondyk, W.H. 1991. Oncogene 6, 1269.

      Productos y aplicaciones relacionados

      Related Products

      Número de referencia Descripción  
      OP13 Anti-N-Myc Mouse mAb (NCM II 100) Precios y disponibilidad

      Categorías

      Life Science Research > Antibodies and Assays > Primary Antibodies